Skip to content

Connecting business. Building understanding. Advancing peace.

Emirates Drug Authority Mandates Prior Approval and Restricts Influencers in Medical Advertising

The Emirates Drug Authority has stressed that prior approval is mandatory before publishing or circulating any medical advertisements across media channels in the UAE. The authority highlighted strict prohibitions against promoting medical products through social media influencers and reiterated requirements for accurate, verified health claims. The regulatory framework was reviewed during the Medical Products Advertising Council in Dubai.

Issuing authority
Emirates Drug Authority
Jurisdiction
United Arab Emirates
Publication date
November 19, 2026
Stage
Final rule
Official source
news.google.com
Illustration: A modern pharmaceutical office and clinical setting in the United Arab Emirates with medication packaging on glass shelves and a digital
Illustration

The Emirates Drug Authority has reinforced regulations governing medical advertisements, emphasizing that prior official approval must be obtained before publishing or distributing promotional material across the UAE, Emirates 24|7 reported. The authority specified that regulations govern claims and promotional practices, explicitly prohibiting the advertising or promotion of medical products through social media influencers.

The directives were detailed during the Medical Products Advertising Council, convened at the Government Accelerators Centre in Emirates Towers, Dubai. The meeting brought together industry representatives, partners, and stakeholders to raise awareness of statutory approval requirements and ensure compliance with updated regulatory frameworks for promotional content.

The review covered regulations for prescription drug advertising across various media, including print, audio, visual formats, outdoor screens, websites, social media platforms, and other digital channels. Stakeholders discussed procedures for submitting approval requests via the electronic system, the submission documents required by advertising medium, and the review stages for audio-visual content.

Under the guidelines, advertising content must remain clear, accurate, and aligned strictly with approved product data and indications while avoiding misleading claims. Disclosures of side effects, risks, and required warnings must be presented based on the product category and target audience, and advertising must not encourage the public to self-diagnose or administer treatments without medical supervision.

Sources

The UECN Brief

Policy updates, China–UAE business news and industry insights, delivered to your inbox.

Language
Subscriptions

Double opt-in: we send a confirmation link. Unsubscribe at any time. Privacy